greeksoup/ stock research
Stock research / United States / KNSA / Planned sales

Kiniksa Pharmaceuticals International, plc planned insider sales

In the last twelve months insiders at Kiniksa Pharmaceuticals International, plc filed 17 Form 144 notices of planned sales, 1.1 million shares worth $54.0 million at the time of filing, from 8 sellers. The latest, filed 3 September 2026: Megna Michael R (officer), 4,600 shares worth $369,380, planned for around 3 September 2026 through Charles Schwab & Co., Inc..

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
3 September 2026Megna Michael ROfficer4,600$369,3803 September 20264,600 shares from 3 September 2026Charles Schwab & Co., Inc.Restricted Stock LapseForm 144
29 July 2026Cole G BradleyDirector3,673$299,09229 July 20263,673 shares from 29 July 2026Charles Schwab & Co., Inc.Restricted Stock LapseForm 144
29 July 2026Tessari EbenFormer Affiliate67,062$5.3 million29 July 2026No matching Form 4 saleCharles Schwab & Co., Inc.Employee Stock Option Exercise; PSU / RSU - See RemarksForm 144
1 May 2026Paolini John F.Officer58,424$3.1 million1 May 202658,424 shares from 1 May 2026Charles Schwab & Co., Inc.Employee Stock Option ExerciseForm 144
28 April 2026Patel Sanj KOfficer, Director344,591$17.8 million28 April 2026556,904 shares from 28 April 2026Charles Schwab & Co., Inc.Employee Stock Option Exercise - See RemarksForm 144
9 April 2026Moat RossOfficer1,703$79,5139 April 20261,703 shares from 9 April 2026Charles Schwab & Co., Inc.Restricted Stock LapseForm 144
9 April 2026Megna Michael ROfficer6,625$309,3219 April 20266,625 shares from 9 April 2026Charles Schwab & Co., Inc.Restricted Stock LapseForm 144
6 April 2026Moat RossOfficer2,367$114,9896 April 20262,367 shares from 6 April 2026Charles Schwab & Co., Inc.Restricted Stock LapseForm 144
6 April 2026Quart Barry DDirector20,000$1.0 million6 April 202620,000 shares from 6 April 2026Charles Schwab & Co., Inc.Employee Stock Option Exercise - see remarksForm 144
6 April 2026Patel Sanj KOfficer, Director219,591$11.0 million6 April 20267,278 shares from 6 April 2026Charles Schwab & Co., Inc.Employee Stock Option Exercise - See RemarksForm 144
9 March 2026Ragosa MarkOfficer36,722$1.7 million9 March 202636,722 shares from 9 March 2026Charles Schwab & Co., Inc.Employee Stock Option ExerciseForm 144
2 March 2026Paolini John F.Officer40,000$1.8 million2 March 202640,000 shares from 2 March 2026Charles Schwab & Co., Inc.Employee Stock Option ExerciseForm 144
15 December 2025Quart Barry DDirector58,889$2.4 million15 December 202538,889 shares from 15 December 2025Charles Schwab & Co., Inc.Employee Stock Option Exercise - see remarksForm 144
8 December 2025Ragosa MarkOfficer72,686$3.0 million8 December 202572,686 shares from 8 December 2025Charles Schwab & Co., Inc.Employee Stock Option Exercise; RSU / PSU - see remarksForm 144
26 November 2025Tessari EbenOfficer48,384$2.1 million26 November 202512,248 shares from 26 November 2025Charles Schwab & Co., Inc.ESPP; Employee Stock Option Exercise - See Remarks; Founders SharesForm 144
17 November 2025Tessari EbenOfficer12,470$514,22517 November 202512,470 shares from 17 November 2025Charles Schwab & Co., Inc.ESPP; Employee Stock Option Exercise; Founders SharesForm 144
31 October 2025Paolini John F.Officer82,542$3.1 million31 October 202582,542 shares from 31 October 2025Charles Schwab & Co., Inc.Employee Stock Option ExerciseForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?